This announcement is a separate document:
上海医药集团股份有限公司关于上海上实集团财务有限公司2024年半年度风险持续评估报告
Shanghai Pharma Group Co., Ltd.'s report on the continued risk assessment of Shanghai Shangshi Group Financial Co., Ltd.'s 2024 semi-annual period.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated